Navigation Links
RoundTable Appoints Senior Healthcare Executives
Date:3/4/2009

New Leadership Will Strengthen Industry Expertise and Operating Capabilities

LAKE FOREST, Ill., March 4 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced the appointment today of two senior healthcare executives adding to the firm's industry expertise and operating capabilities. Christopher J. Worrell has joined as Chief Executive Officer of CorePharma, one of RoundTable's portfolio companies and a leading developer and manufacturer of solid dose generic pharmaceuticals. Greg L. Baumli will be serving as Senior Vice President, Manufacturing providing guidance and oversight to each of the firm's portfolio companies in the those operational areas critical to the achievement of their growth objectives.

Mr. Worrell has 15 years of pharmaceutical healthcare experience specializing in the manufacturing, wholesaling, and distribution of generic pharmaceuticals. "RoundTable is pleased to have Chris join the CorePharma team," said Jack McGinley, Founding and Operating Partner of RoundTable and Chairman of the Board of CorePharma. "Since our acquisition of CorePharma in 2005, the company has made significant progress toward achieving its strategic and operating goals. We are confident that Chris will be a valuable resource to the CorePharma team bringing his extensive knowledge of the generic pharmaceutical market and proven operating abilities."

"I am excited to work with the CorePharma team," said Mr. Worrell. "CorePharma has developed a diversified portfolio of generic pharmaceutical products with an impressive pipeline of new products in various stages of development. The company has tremendous potential and is well positioned, both internally and by working with the RoundTable team, to execute its growth strategy."

Mr. Baumli has over 25 years of experience in medical device manufacturing most recently having responsibility for a global network of manufacturing locations with over $1 billion in value of production. "The addition of Greg to our management team is consistent with our strategy of providing operating resources to our portfolio companies to help them improve their long-term growth and profitability," said Joseph F. Damico, Founding and Operating Partner of RoundTable. "Greg will bring the knowledge and set of skills and experiences typically seen in multi-billion dollar organizations. All of RoundTable's portfolio companies will benefit from his considerable operating expertise and talents."

"RoundTable's success is clearly due to its strategy of bringing unparalleled operating resources to each of its portfolio companies," said Mr. Baumli. "I am eager to begin working with these companies to help them achieve their short and long-term objectives."

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise. RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs, and corporate partners who share a vision and believe in the value creation potential of its partnership model. RoundTable currently manages $1.1 billion in capital, including two equity funds totaling $900 million and a subordinated debt fund of $200 million. More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com .

About CorePharma LLC

CorePharma, Middlesex, NJ, is a leading developer and manufacturer of solid dose generic pharmaceuticals, including prescription and over-the-counter products. The company currently has over 30 FDA-approved products on the market, with a pipeline of over 25 new products in various stages of development and regulatory approval. CorePharma's product portfolio is well diversified, spanning the spectrum of therapeutic specialties, and includes controlled drug products as well as immediate and modified release dosage form products.


'/>"/>
SOURCE RoundTable Healthcare Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Stevens Health, Technology and Society roundtable: Sept. 19
2. NFIB Joins AARP, Business Roundtable and SEIU in Divided We Fail
3. Lucian Leape Institute Announces First Roundtable
4. OIG and HCCA Issue Government-Industry Roundtable Report
5. Lucian Leape Institute First Roundtable: A Resounding Success
6. Remarks By President Bush and President Kikwete of Tanzania at Roundtable on Pepfar
7. BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
8. Genomic Health to Participate in Leerink Swann Roundtable Conference
9. Privacy Experts Roundtable Report Will Highlight Privacy & Security Week
10. Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program
11. Caliper Life Sciences to Present at Leerink Swanns 3rd Annual Life Science Tools Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Early this week, Team Iconic at J. Walter Thompson ... as the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé ... their product, through activities that focus on better farming, better lives and better cocoa. ...
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx ... dynamic expert and thoughtful presentation to give attendees a better sense of how to ... free to attend, but registration is required. , Rehabilitation of Offensive Lineman ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency ... find. Unfortunately, this can leave patients with dental emergencies at risk of losing a ... offering emergency dental care. , Common dental emergencies include:, , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... will bring together more than 200 of the country’s top healthcare executives to ... , “The true benefit of the Forum is the provider-centric perspective, experience, expertise ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... VIEW, Calif. , Feb. 10, 2016 ... of a synergistic confluence of various technologies ... value propositions, previously unavailable. These opportunities create ... and convergence, in turn, drives the development ... entrepreneurial scenario is characterized by technology convergences, ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... biopharmaceutical company developing novel, clinical-stage therapies for sickle cell ... an underwritten public offering of 29,090,910 units at a ... unit consists of one share of the Company,s common ... the Company,s common stock at an exercise price of ...
(Date:2/10/2016)... , Feb. 10, 2016 /PRNewswire/ - The President ... has announced the release of an anti-radiation product ... a revolutionary breakthrough in the treatment of cancer ... exposure. It will assist in the healing of ... It will also protect only the healthy cells ...
Breaking Medicine Technology: